Drug Discovery & Development - September 27, 2010
Toxikon, an FDA-registered and independent contract research organization, has added the Comet Assay IV Analysis System to the breadth of its comprehensive genetic and molecular toxicology study offerings.
This technology, developed by Perceptive Instruments Ltd., is considered to be at the forefront of cancer research. Whether it is used to accelerate the development of cancer-fighting drugs or for environmental monitoring, genetic toxicology platforms, like the Comet Assay IV, are important tools in high demand among life science industries.
Along with the Comet Assay, Toxikon also provides a range of services from bioanalysis to chronic studies to FISH, blue and green screen assays to a full battery of genetic toxicology studies for premarket approval and IND submission. Additionally, Toxikon’s state-of-the-art facilities and experienced lab management provide specific solutions that comply and sound data.
Identification of biomarkers linked to adverse effects and target organ toxicities will always be central to preclinical and clinical studies.
Date: September 1, 2010
Source: Toxikon
This technology, developed by Perceptive Instruments Ltd., is considered to be at the forefront of cancer research. Whether it is used to accelerate the development of cancer-fighting drugs or for environmental monitoring, genetic toxicology platforms, like the Comet Assay IV, are important tools in high demand among life science industries.
Along with the Comet Assay, Toxikon also provides a range of services from bioanalysis to chronic studies to FISH, blue and green screen assays to a full battery of genetic toxicology studies for premarket approval and IND submission. Additionally, Toxikon’s state-of-the-art facilities and experienced lab management provide specific solutions that comply and sound data.
Identification of biomarkers linked to adverse effects and target organ toxicities will always be central to preclinical and clinical studies.
Date: September 1, 2010
Source: Toxikon
No hay comentarios:
Publicar un comentario